|By Business Wire||
|May 15, 2014 05:46 PM EDT||
Ambry Genetics is proud to announce that it has published results illustrating the performance of its custom BRCAplus panel in the peer reviewed journal PLOS ONE, demonstrating best-in-class sensitivity and specificity.
The study assessed the BRCAplus panel, which couples next-generation sequencing with array comparative genomic hybridization, to provide comprehensive mutation analysis in six high-risk genes: BRCA1, BRCA2, PTEN, TP53, CDH1, and STK11. Validation of the BRCAplus assay, with 250 previously characterized samples, resulted in 100% detection of 3,025 known variants and an analytical specificity of 99.999%.
“Ambry was one of the first diagnostic labs to implement next-generation sequencing, and we have leveraged that 7+ years of experience to develop our BRCAplus assay and other custom designed panels with unparalleled sensitivity and specificity,” stated Aaron Elliott, PhD, Vice President of Research and Development. “There are a multitude of technical variables that impact the quality of a diagnostic sequencing test including the target enrichment technology and design, sequencing instrumentation and bioinformatics platform. With the plethora of labs launching NGS based tests, it's important to remember all tests are not created equal.”
Analysis of the clinical performance of the first 3,000 BRCAplus samples referred for testing revealed an average coverage greater than 9,000X per target base pair resulting in excellent specificity and the sensitivity to detect low level mosaicism and limit allele-drop out. The unique design of the assay enabled the detection of pathogenic mutations missed by previous testing.
“Our detection of disease-causing mutations in patients who would have otherwise gone undiagnosed and those who had previously received inaccurate negative results highlights the clinical utility of BRCAplus and its advantages over traditional testing approaches,” stated AJ Stuenkel, MS, CGC, Manager of Cancer Reporting. “These novel techniques allow us to provide answers to even more patients and their families, which is always our ultimate goal.”
About Ambry Genetics:
Ambry Genetics is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified commercial clinical laboratory with headquarters in Orange County, California. Since its founding in 1999, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services, particularly in sequencing and array services. Ambry has established a reputation for unparalleled service and for over a decade has been at the forefront of applying new technologies to the clinical molecular diagnostics market and to the advancement of disease research. To learn more about testing and services available through Ambry, please visit www.ambrygen.com
"Dice has been around for the last 20 years. We have been helping tech professionals find new jobs and career opportunities," explained Manish Dixit, VP of Product and Engineering at Dice, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 7, 2016 01:45 PM EST Reads: 1,094
Get deep visibility into the performance of your databases and expert advice for performance optimization and tuning. You can't get application performance without database performance. Give everyone on the team a comprehensive view of how every aspect of the system affects performance across SQL database operations, host server and OS, virtualization resources and storage I/O. Quickly find bottlenecks and troubleshoot complex problems.
Dec. 7, 2016 01:30 PM EST Reads: 2,141
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
Dec. 7, 2016 01:30 PM EST Reads: 332
"We are a custom software development, engineering firm. We specialize in cloud applications from helping customers that have on-premise applications migrating to the cloud, to helping customers design brand new apps in the cloud. And we specialize in mobile apps," explained Peter Di Stefano, Vice President of Marketing at Impiger Technologies, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 7, 2016 01:24 PM EST
Dec. 7, 2016 12:45 PM EST Reads: 1,070
Dec. 7, 2016 12:35 PM EST Reads: 192
Dec. 7, 2016 12:30 PM EST Reads: 608
Dec. 7, 2016 12:30 PM EST Reads: 715
Dec. 7, 2016 12:30 PM EST Reads: 834
Dec. 7, 2016 12:00 PM EST Reads: 589
Dec. 7, 2016 12:00 PM EST Reads: 1,112
Dec. 7, 2016 11:47 AM EST Reads: 234
Dec. 7, 2016 11:45 AM EST Reads: 1,022
Dec. 7, 2016 11:45 AM EST Reads: 456
Dec. 7, 2016 11:30 AM EST Reads: 652